Barrier Repair Sunscreen SPF 50+

Multiple studies confirm that oxybenzone and octinoxate exhibit estrogenic and antiandrogenic activity which can disrupt thyroid and reproductive hormones [1.2].

Not approved by the US FDA as a sunscreen active and subject to strict EU impurity limits for the reproductive toxicant di n hexyl phthalate.

Clinical trials demonstrate systemic absorption into the bloodstream exceeding the FDA threshold requiring further safety testing.

Formulated with decyl glucoside as a stabilizer which has been identified as a hidden allergen responsible for contact dermatitis in sunscreen users.

Restricted in the European Union from use in spray and aerosol cosmetics due to potential inhalation toxicity [1.17].

Lecithin should not be used in cosmetic products containing nitrosating agents due to the potential formation of carcinogenic nitrosamine compounds.

The European Union is restricting this ingredient to a maximum concentration of one tenth of a percent in leave on cosmetics effective June 2027.

Recognized as a frequent cause of allergic contact dermatitis especially in individuals with eczema or compromised skin barriers.

Historically rated as mildly comedogenic in animal models but modern dermatological consensus indicates it is unlikely to clog pores in typical cosmetic formulations.

Cyclopentasiloxane is restricted in the European Union for wash off cosmetics due to environmental accumulation, and it may contain trace amounts of cyclotetrasiloxane, which is classified as toxic to reproduction.

Poorly biodegradable in the environment and can accumulate in aquatic ecosystems where it may mobilize heavy metals.

The ethoxylated excipient Polysorbate 20 may be contaminated with trace amounts of 1 4 dioxane and ethylene oxide which are probable human carcinogens as byproducts of the manufacturing process [3.4].

Both components are documented, albeit rare, contact allergens that can trigger allergic contact dermatitis in susceptible individuals.